Kamada Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $180.5M+12.1% YoYTTM through 31 Dec 2025
Net Income $20.2M+39.7% YoYTTM through 30 Sep 2025
Free Cash Flow $15.7MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 42.3% |
| EBITDA Margin | 15.4% |
| Operating Margin | 14.5% |
| Net Margin | 11.2% |
Returns
7.5%ROE
5.3%ROA
8.0%ROIC
Balance Sheet Health
Debt / Equity0.04x
Current Ratio4.07x
Net Debt-$63.9Mnet cash position
Cash & Equivalents$75.5M
Quality Metrics
Piotroski F-Score6 / 9
FCF Margin8.7%
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $180.5M
Diluted EPSFY2025: $0.35
Dividend
$0.25Per share, FY20263.36%Yield1 yrsStreak
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Proprietary Products | $156.2M | ||
| Distribution | $24.3M |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.